Ray Dalio Jazz Pharmaceuticals PLC Transaction History
Bridgewater Associates, LP
- $20.7 Billion
- Q1 2025
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Bridgewater Associates, LP holds 250,947 shares of JAZZ stock, worth $26.9 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
250,947
Previous 192,035
30.68%
Holding current value
$26.9 Million
Previous $23.6 Million
31.74%
% of portfolio
0.15%
Previous 0.11%
Shares
14 transactions
Others Institutions Holding JAZZ
# of Institutions
601Shares Held
60.5MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$658 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$644 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$264 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$249 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$211 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.71B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...